-
Bayer AG and Meituan Deepen Partnership to Transform Skin Health Market in China
•
Bayer AG (ETR: BAYN), a leading German multinational pharmaceutical and life sciences company, has expanded its partnership with Meituan’s medical and healthcare business unit, a major player in China’s delivery services. The new collaboration will concentrate on the skin health sector, with a focus on online retail, digital marketing, and…
-
JD Healthcare and Genrix Bio Join Forces to Revolutionize Patient Care and Pharmacy Services
•
JD Healthcare, a subsidiary of China’s e-commerce juggernaut JD.com (NASDAQ: JD), has formed a strategic partnership with Chongqing Genrix Biopharmaceutical Co., Ltd. This alliance combines Genrix Biopharmaceutical’s prowess in drug research and development with JD Healthcare’s extensive resource and ecological advantages in medical treatment, medication, health management, and insurance. Together,…
-
ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the Hong Kong stock exchange (HKG: 9955), has announced that it has secured marketing approval from the National Medical Products Administration (NMPA) for its innovative digital medicine product, ClouDT-01, designed for the treatment of diabetes. Leveraging…
-
E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services
•
E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured nearly RMB 100 million (USD 13.8 million) in a Series C financing round. The funding round attracted notable investors such as Ameba Capital, Ventech China, and Borchid Capital. The capital raised is intended to fuel…
-
Jiangsu Yuyue Medical Teams Up with China Unicom for Digital Healthcare Innovation
•
Shanghai-based Jiangsu Yuyue Medical Equipment Inc. (SHE: 002223) has announced a strategic partnership with China Unicom, aiming to enhance digitalization in enterprise management, product digitization, and global technological empowerment. China Unicom will utilize its network, cloud, communication technology, and AI algorithms to advance the intelligence and digital upgrade of Yuyue’s…
-
Baidu Health Partners with Souyao to Boost Offline Pharmacy Services in China
•
Baidu Health has entered into a partnership with Beijing-based pharmaceutical business service provider Souyao. The collaboration will capitalize on Baidu’s resource advantages in areas such as search engines, map navigation, health services, artificial intelligence (AI), and e-commerce to offer comprehensive technical and operational services for brick-and-mortar pharmacies. The goal is…
-
SciClone Pharmaceuticals Teams Up with SPH Health and Hi Dr to Launch Internet Hospital in China
•
SciClone Pharmaceuticals Inc., (HKG: 6600), a prominent player in China’s pharmaceutical industry, has joined forces with SPH Health Commerce Co., Ltd and Hi Dr to establish an Internet hospital. The tripartite partnership aims to leverage digital healthcare solutions, although no financial details of the agreement have been disclosed. SciClone, known…
-
China’s State Council Unveils 26 Initiatives to Enhance Grey-hair Economy
•
The State Council has unveiled the “Opinions on Developing the Grey-hair Economy to Boost Wellbeing of the Elderly,” outlining 26 initiatives aimed at enhancing the quality of life for the aging population through improved livelihood, product supply, industrial growth, and security measures. Key recommendations include the optimization of elderly health…
-
ClouDr Partners with Yangtze River Pharmaceutical to Digitize Chronic Disease Marketing
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading as “ClouDr” (HKG: 9955), has entered into a partnership with fellow Chinese company Yangtze River Pharmaceutical (Group) Co., Ltd. The collaboration will concentrate on providing digitalized marketing services within specific chronic disease sectors, with both parties looking to expand and deepen their…
-
AstraZeneca Launches Evinova to Enhance Global Clinical Development with Digital Health Solutions
•
UK-based AstraZeneca (AZ; NASDAQ: AZN) has launched Evinova, a digital health solutions provider, with the aim of supporting global clinical development. Evinova offers AI-enabled technologies and services to clinical trial (CT) sponsors, clinical research organizations (CROs), CT site care teams, and patients. The new business unit will initially focus on…
-
Bayer Partners with Mahana Therapeutics to Market Digital Health Technologies
•
Germany-headquartered Bayer (ETR: BAYN) has announced a strategic partnership with US digital developer Mahana Therapeutics. The collaboration focuses on the distribution and marketing of Mahana’s digital technologies, further expanding Bayer’s foray into the digital health sector. This move follows Bayer’s launch earlier this year of a precision health product development…
-
Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China
•
US-based Medtronic Inc., (NYSE: MDT) has launched AiBLE, an innovative ecological ecosystem concept for orthopedics, in the Chinese market. This collaborative platform aims to connect industry, academia, research, and medicine, leveraging existing orthopedic integration platforms, industry chain capabilities, digitalization, and artificial intelligence technologies. With an open and collaborative approach, Medtronic…
-
Zhejiang Dian Diagnostics Partners with Meituan for Digital Healthcare Services Expansion
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a prominent medical diagnostics company based in China, has entered into a strategic partnership with Meituan, the country’s leading delivery giant, to explore new digital and intelligent medical and healthcare service models. The collaboration aims to leverage the strengths of both companies to…
-
Roche Partners with China Resource Medicine to Promote Xofluza in China
•
Swiss pharmaceutical giant Roche (SWX: ROG) has entered into a partnership with China-based China Resource Medicine Commercial Holdings Ltd to jointly promote the anti-influenza drug Xofluza (baloxavir marboxil) in China. Under the agreement, Roche will continue to handle channel promotion for the drug in major hospitals, while CR Medicine Commercial…
-
Zhongchao and Johnson & Johnson Renew Partnership for Digital Health Services
•
Introduction Zhongchao Inc. (NASDAQ: ZCMD), a Shanghai-based online health education provider, has announced a renewed agreement with US major Johnson & Johnson (J&J, NYSE: JNJ). This partnership, initially established in 2017 and renewed in 2020, is expected to further enhance cooperation in the innovative healthcare field. Specifically, Zhongchao will provide…
-
China Optimizes Medical Insurance Policies for COVID-19 Treatment
•
The National Healthcare Security Administration (NHSA), Ministry of Finance, National Health Commission, and Chinese Center for Disease Control and Prevention have released a Notice on “Optimizing Relevant Medical Insurance Policies for Treatment Expenses of Patients with Novel Coronavirus Infection after Implementation of ‘Class B and Class B Management’”. The guidelines…
-
PingAn Good Doctor Partners to Establish Lifestyle Medicine
•
China-based PingAn Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good Doctor, has struck a partnership with the Shenzhen Hospital of Southern Medical University and Shenzhen Community Health Association (SCHA) to establish lifestyle medicine. Financial details of the partnership were not disclosed. PingAn Good Doctor’s ServicesPingAn Good…
-
Luye Pharma Partners with Nhwa and Fine Hin to Commercialize Toludesvenlafaxine
•
China-based Luye Pharma Group (HKG: 2186), Jiangsu Nhwa Pharmaceutical Co., Ltd (SHE: 002262), and Beijing Fine Hin Mobile Medical Technology Co., Ltd have agreed to leverage their respective expertise, platform advantages, and commercialization resources to bolster the commercialization of Luye’s Category 1 chemical drug toludesvenlafaxine (LY03005), an extended-release treatment for…
-
Luca Healthcare Partners with Cambridge Cognition to Launch Cognitive Tools in China
•
China-based digital health solutions provider Luca Healthcare has announced a strategic partnership and license agreement with UK firm Cambridge Cognition. Under the agreement, Luca has secured a 10-year exclusive license to commercialize Cambridge Cognition’s suite of cognitive assessment tools in mainland China. Financial details of the agreement were not disclosed.…
-
China Releases 14th Five-Year Plan for National Health Informatization
•
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau of Disease Control and Prevention have released the “National Health Informatization Planning” document for the 14th Five-Year Plan (FYP) period (2021-2025). This document outlines the achievements and challenges of the previous 13th FYP period and…
